VIP and PACAP induce shift to a Th2 response by upregulating B7.2 expression.

Area of Science:

• Immunology
• Neuroendocrinology
• Cellular Biology

Background:

• Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP) are neuropeptides found in the lymphoid microenvironment.
• These peptides possess immunomodulatory functions, with known anti-inflammatory properties.
• Their effects on macrophages, particularly concerning antigen presentation and T cell differentiation, require further elucidation.

Purpose of the Study:

• To investigate the role of VIP and PACAP in modulating macrophage B7 expression and costimulatory capacity for CD4+ T cells.
• To determine the impact of VIP and PACAP on macrophage-induced Th1/Th2 cell differentiation, both in vitro and in vivo.
• To elucidate the signaling pathways and receptors involved in these VIP/PACAP-mediated effects.

Main Methods:

• Assessing B7.1, B7.2, MHC class II, and ICAM-1 expression on macrophages treated with VIP and PACAP.
• Evaluating macrophage-induced T cell proliferation using anti-CD3 or allogeneic stimulation.
• Investigating the involvement of the VPAC1 receptor and the cAMP/PKA pathway.
• Analyzing mRNA and protein levels of B7.2.
• Measuring cytokine production (IFN-γ, IL-2, IL-4, IL-5) from differentiated T cells.
• Administering VIP or PACAP in vivo to antigen-immunized mice and assessing immune cell populations and antibody isotypes.

Main Results:

• VIP and PACAP significantly upregulated B7.2 expression on macrophages, but not B7.1, MHC class II, or ICAM-1.
• Treated macrophages exhibited enhanced costimulatory activity, promoting naïve T cell proliferation.
• The VPAC1 receptor and the cAMP/PKA pathway were identified as key mediators of these effects.
• VIP/PACAP treatment led to a shift in T cell differentiation towards a Th2 phenotype, characterized by increased IL-4 and IL-5 production and decreased Th1 cytokines (IFN-γ, IL-2).
• In vivo studies confirmed reduced IFN-γ secreting cells and increased IL-4 secreting cells following VIP or PACAP administration.

Conclusions:

• VIP and PACAP enhance macrophage costimulatory function primarily through the upregulation of B7.2 expression.
• This modulation of macrophage phenotype promotes Th2 cell differentiation and suppresses Th1 responses.
• The findings suggest that VIP and PACAP contribute to the overall anti-inflammatory activity of neuropeptides by inhibiting Th1-dominated immune responses.